Active Ingredient History

NOW
  • Now
Etifoxine, sold under the trade name Stresam among others, is a nonbenzodiazepine anxiolytic agent, primarily indicated for short-term management of adjustment disorder, specifically instances of situational depression accompanied by anxiety, such as stress-induced anxiety. Administration is by mouth. Side effects associated with etifoxine use include slight drowsiness, headache, skin eruptions, and allergic reactions. In rare cases, etifoxine has been linked to severe skin and liver toxicity, as well as menstrual bleeding between periods. Unlike benzodiazepines, etifoxine does not cause sedation or lack of coordination. Etifoxine acts as a GABAA receptor positive allosteric modulator and as a ligand for translocator proteins. Both mechanisms are conjectured to contribute to its anxiolytic properties.   Wikipedia

  • SMILES: CCNC1=Nc2ccc(Cl)cc2C(C)(O1)c3ccccc3
  • InChIKey: IBYCYJFUEJQSMK-UHFFFAOYSA-N
  • Mol. Mass: 300.79
  • ALogP: 4.23
  • ChEMBL Molecule:
More Chemistry
2-ethylamino-6-chloro-4-methyl-4-phenyl-4h-3,1-benzoxazine | 36-801 | etafenoxine | etafenoxine hydrochloride | etifoxin | etifoxine | etifoxine hydrochloride | hoe 36801 | hoe-36801 | stresam

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue